NFKB1 and inflammatory response: Wang et al. indicated that GPBAR1 inhibited the NF-κB pathway by mediating the interaction between Iκbα and β-arrestin2 and that GPBAR1 was a negative regulator of NF-κB-mediated liver inflammation (Wang et al., 2011).